111 related articles for article (PubMed ID: 22227189)
1. The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells.
Choi S; Kim JY; Park JH; Lee ST; Han IO; Oh ES
Biochem Biophys Res Commun; 2012 Jan; 417(4):1260-4. PubMed ID: 22227189
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1α promotes extracellular shedding of syndecan-2 via induction of matrix metalloproteinase-7 expression.
Kwon MJ; Hong E; Choi Y; Kang DH; Oh ES
Biochem Biophys Res Commun; 2014 Apr; 446(2):487-92. PubMed ID: 24613844
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells.
Jang B; Jung H; Chung H; Moon BI; Oh ES
Biochem Biophys Res Commun; 2016 Aug; 477(1):47-53. PubMed ID: 27270030
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.
Jang B; Jung H; Choi S; Lee YH; Lee ST; Oh ES
J Biol Chem; 2017 Sep; 292(39):16321-16332. PubMed ID: 28821612
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine 51 residue of the syndecan-2 extracellular domain is involved in the interaction with and activation of pro-matrix metalloproteinase-7.
Jang B; Yun JH; Choi S; Park J; Shin DH; Lee ST; Lee W; Oh ES
Sci Rep; 2019 Jul; 9(1):10625. PubMed ID: 31337828
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells.
Ryu HY; Lee J; Yang S; Park H; Choi S; Jung KC; Lee ST; Seong JK; Han IO; Oh ES
J Biol Chem; 2009 Dec; 284(51):35692-701. PubMed ID: 19858218
[TBL] [Abstract][Full Text] [Related]
7. Everolimus exerts anticancer effects through inhibiting the interaction of matrix metalloproteinase-7 with syndecan-2 in colon cancer cells.
Lee S; Jang B; Hwang J; Lee Y; Cho S; Yang H; Yun JH; Shin DH; Lee W; Oh ES
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1067-C1079. PubMed ID: 38314724
[TBL] [Abstract][Full Text] [Related]
8. Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.
Choi S; Choi Y; Jun E; Kim IS; Kim SE; Jung SA; Oh ES
Oncotarget; 2015 Feb; 6(6):3874-86. PubMed ID: 25686828
[TBL] [Abstract][Full Text] [Related]
9. The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.
Kwon MJ; Kim Y; Choi Y; Kim SH; Park S; Han I; Kang DH; Oh ES
Biochem Biophys Res Commun; 2013 Feb; 431(3):415-20. PubMed ID: 23333331
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.
Lee H; Kim Y; Choi Y; Choi S; Hong E; Oh ES
Biochem Biophys Res Commun; 2011 May; 409(1):148-53. PubMed ID: 21569759
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation.
Choi Y; Kim H; Chung H; Hwang JS; Shin JA; Han IO; Oh ES
Biochem Biophys Res Commun; 2010 Jan; 391(1):921-5. PubMed ID: 19962968
[TBL] [Abstract][Full Text] [Related]
12. Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide.
Jang B; Kim A; Lee Y; Hwang J; Sung JY; Jang EJ; Kim YN; Yun JH; Han J; Song JJ; Lee W; Oh ES
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682569
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells.
Asundi VK; Erdman R; Stahl RC; Carey DJ
J Neurosci Res; 2003 Sep; 73(5):593-602. PubMed ID: 12929127
[TBL] [Abstract][Full Text] [Related]
14.
Jeon JI; Lee KH; Kim JM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769248
[No Abstract] [Full Text] [Related]
15. A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis.
Munesue S; Yoshitomi Y; Kusano Y; Koyama Y; Nishiyama A; Nakanishi H; Miyazaki K; Ishimaru T; Miyaura S; Okayama M; Oguri K
J Biol Chem; 2007 Sep; 282(38):28164-74. PubMed ID: 17623663
[TBL] [Abstract][Full Text] [Related]
16. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
[TBL] [Abstract][Full Text] [Related]
17. Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.
Ding K; Lopez-Burks M; Sánchez-Duran JA; Korc M; Lander AD
J Cell Biol; 2005 Nov; 171(4):729-38. PubMed ID: 16286510
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Ishikawa T; Kimura Y; Hirano H; Higashi S
J Biol Chem; 2017 Dec; 292(50):20769-20784. PubMed ID: 29046355
[TBL] [Abstract][Full Text] [Related]
19. Heparanase-Regulated Syndecan-1 Shedding Facilitates Herpes Simplex Virus 1 Egress.
Hadigal S; Koganti R; Yadavalli T; Agelidis A; Suryawanshi R; Shukla D
J Virol; 2020 Feb; 94(6):. PubMed ID: 31827001
[TBL] [Abstract][Full Text] [Related]
20. Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.
Manon-Jensen T; Multhaupt HA; Couchman JR
FEBS J; 2013 May; 280(10):2320-31. PubMed ID: 23384311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
